Previsão

Não temos dados de analistas para esta empresa.

Notícias Ir para o feed de notícias

Hapvida Q1 2026: profitability improves as loss ratio falls

Hapvida reports a marked improvement in the loss ratio to 72.2% in Q1 2026 and an adjusted EBITDA of R$803m (margin 10.2%), indicating successful measures to control medical costs. Despite a decline of 44,500 insured individuals to 8.68 million, revenue remained stable at R$7,892m and adjusted net income rose to R$244m. Administrative expenses and legal disputes weighed on the cost structure, while free cash flow was robust at R$443m. Management is pursuing a five‑pillar turnaround focused on rational growth, network expansion, AI and capital discipline; analysts expect a return to profitability in 2026. » Mais em de.investing.com
Hapvida: Q4‑2025 profit falls 65% amid increased customer churn

Hapvida reports an adjusted net profit decline of 64.9% in Q4 2025 to R$181m on a 5.9% rise in net revenue to R$7.915bn. Adjusted EBITDA fell 32.8% and the EBITDA margin dropped 520 basis points to 9.0%, while the cash‑MLR rose to 75.5%. On an organic basis the company lost 140,000 health plan members, mainly in the Southeast and South, and free cash flow was negative R$233m. Net debt increased to R$5.183bn and management announced a six‑pillar turnaround plan focused on customer retention, cost discipline and strengthening technology. » Mais em de.investing.com
Hapvida Q3 2025: revenue rises, EBITDA falls on higher medical loss ratio

Hapvida reported net revenue of R$ 7,775 million in Q3 2025 (+6% y/y), but missed analyst expectations. The Cash Medical Loss Ratio rose to 75.2%, driven by higher hospital and emergency usage, which pushed adjusted EBITDA down to R$ 746 million (-17.6% q/q) and the EBITDA margin to 9.6%. Adjusted net income rose to R$ 338 million, while the stock fell sharply, losing about 33%. Management expects rate adjustments of around 10% by year-end and relies on network expansion and technology use to improve margins. » Mais em de.investing.com

Dividendos históricos Dividendos

Todos os indicadores de dividendos Todos os indicadores

Em 2022, HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS já distribuiu € 0,013 em dividendos. A última distribuição ocorreu em janeiro de 2022.

Dados financeiros da empresa

No último trimestre, HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS registou receitas de € 206,32 mi e um ganho líquido de -€ 12,91 mi

(EUR)	junho de 2026	YoY
Receitas	206,32 mi	83,41%
Ganho bruto	161,41 mi	58,62%
Ganho líquido	-12,91 mi	75,07%
EBITDA	63,23 mi	46,29%

Dados fundamentais

Métrica	Valor
Capitalização bolsista	€ 500,56 mi
Número de ações	475,06 mi
Máximo/mínimo de 52 semanas	€ 6,38 - € 1,01
Dividendos	Não
Beta	0,26
PER (PE Ratio)	-16,92
PEG (PEG Ratio)	0,04
P/VC (PB Ratio)	0,06
P/V (PS Ratio)	0,16

Perfil da empresa

Hapvida Participações e Investimentos S.A. ist zusammen mit ihren Tochtergesellschaften im Gesundheitssektor in Brasilien tätig. Das Unternehmen bietet Kranken- und Zahnversicherungen an. Es bietet auch medizinische und paramedizinische, Labor-, Diagnose-, Bildgebungs- und Ultraschalldienste an und organisiert Kurse, Vorträge, Seminare und andere Veranstaltungen. Darüber hinaus beschäftigt sich das Unternehmen mit der Verwaltung, Beratung und Implementierung von Betriebssystemen für private Gesundheitsvorsorgepläne im Dentalbereich, der Verwaltung, Beratung, Implementierung und dem Verkauf von individuellen, familiären und kollektiven Gesundheitssystemen und -plänen sowie der Erstattung von medizinischen, zahnmedizinischen, Krankenhaus- und Gesundheitskosten an seine Begünstigten und bietet Gesundheitsassistenzdienste an. Das Unternehmen betreibt ein Netzwerk von 47 Krankenhäusern, 47 Notfallstationen, 199 Kliniken und 172 Diagnosezentren. Das Unternehmen wurde 1979 gegründet und hat seinen Hauptsitz in Fortaleza, Brasilien. Hapvida Participações e Investimentos S.A. ist als Tochtergesellschaft von PPAR Pinheiro Participações S.A. tätig.